These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15553928)

  • 1. Coronary stents reduce restenosis and repeat revascularizations and may also improve survival.
    Vik-Mo H; Bønaa KH
    Scand Cardiovasc J; 2004 Aug; 38(4):195-6. PubMed ID: 15553928
    [No Abstract]   [Full Text] [Related]  

  • 2. IIb or not IIb? Toward a rational application of left main stenting.
    Uretsky BF
    J Am Coll Cardiol; 2010 Jun; 55(23):2553-5. PubMed ID: 20513594
    [No Abstract]   [Full Text] [Related]  

  • 3. Brachytherapy and drug-eluting stents.
    Moses JW
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():30B-32B; discussion 32B-33B. PubMed ID: 12724584
    [No Abstract]   [Full Text] [Related]  

  • 4. A cagey proposition.
    Ho YD; Lee DP
    J Invasive Cardiol; 2008 Jan; 20(1):28. PubMed ID: 18174615
    [No Abstract]   [Full Text] [Related]  

  • 5. IVUS guidance results in lower in-stent restenosis: A chapter for a history book?
    Colombo A
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):322-3. PubMed ID: 12822149
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of drug-eluting stents in everyday clinical practice: can the results of randomised trials be achieved in the "real world"?
    Sionis DG
    Hellenic J Cardiol; 2005; 46(2):124-7. PubMed ID: 15847132
    [No Abstract]   [Full Text] [Related]  

  • 7. Seal to prevent spreading: it makes sense!
    Colombo A
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):441-2. PubMed ID: 12652490
    [No Abstract]   [Full Text] [Related]  

  • 8. Fractional flow reserve-guided stent therapy for multivessel disease: taking a closer look.
    Applegate RJ
    J Am Coll Cardiol; 2010 Jun; 55(25):2822-4. PubMed ID: 20579538
    [No Abstract]   [Full Text] [Related]  

  • 9. [A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. Results of TAXUS IV].
    Liakishev AA
    Kardiologiia; 2004; 44(3):77. PubMed ID: 15489834
    [No Abstract]   [Full Text] [Related]  

  • 10. Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents.
    Dardas PS; Tsikaderis DD; Mezilis NE; Hatzimiltiadis S
    Hellenic J Cardiol; 2005; 46(2):117-23. PubMed ID: 15847131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients.
    Loutfi M; Mulvihill NT; Boccalatte M; Farah B; Fajadet J; Marco J
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):451-4. PubMed ID: 12652493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forget Mars and venus, men and women are from the same planet after all.
    Parikh PB; Gruberg L
    J Invasive Cardiol; 2012 Jun; 24(6):261-2. PubMed ID: 22684378
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The forgotten player of in-stent restenosis: endothelial dysfunction.
    Celik T; Iyisoy A; Kursaklioglu H; Celik M
    Int J Cardiol; 2008 Jun; 126(3):443-4. PubMed ID: 17466392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender medicine and drug eluting coronary stents.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):814-6. PubMed ID: 21104730
    [No Abstract]   [Full Text] [Related]  

  • 17. Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):799-800. PubMed ID: 17377984
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotics and stent type for primary PCI.
    Mukherjee D
    Lancet; 2011 Jun; 377(9784):2154-6. PubMed ID: 21665264
    [No Abstract]   [Full Text] [Related]  

  • 20. Late target lesion revascularization following drug-eluting stents - looking back and forward to success.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):304-5. PubMed ID: 18288752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.